Open AccessS927 Serum Biologic Levels for Achieving Endoscopic, Biomarker, and Clinical Remission in Post-Operative Crohn’s Disease
Author(s) -
Yushan Pan,
Waseem Ahmed,
Prerna Mahtani,
Rochelle Wong,
Randy Longman,
Ellen Scherl,
Dana J. Lukin,
Robert Battat
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000777240.34426.8c
Subject(s) - medicine , infliximab , calprotectin , adalimumab , gastroenterology , crohn's disease , biomarker , ustekinumab , faecal calprotectin , colonoscopy , therapeutic drug monitoring , retrospective cohort study , surgery , inflammatory bowel disease , disease , pharmacokinetics , colorectal cancer , biochemistry , chemistry , cancer